O	O	O	0	10	Modulation	Modulation	B-NP	NN	O	14	SUB	O
O	O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	14	24	endogenous	endogenous	B-NP	JJ	O	13	NMOD	O
T1	B-Protein	B-Protein	25	27	IL	IL	I-NP	NN	B-protein	7	NMOD	B-protein
T1	I-Protein	I-Protein	27	28	-	-	O	HYPH	I-protein	7	P	I-protein
T1	I-Protein	I-Protein	28	29	1	1	B-NP	CD	I-protein	7	NMOD	I-protein
T1	I-Protein	I-Protein	30	34	beta	beta	I-NP	SYM	I-protein	3	NMOD	I-protein
O	O	O	35	38	and	and	I-NP	CC	O	3	NMOD	O
T2	B-Protein	B-Protein	39	41	IL	IL	I-NP	NN	B-protein	3	NMOD	B-protein
T2	I-Protein	I-Protein	41	42	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T2	I-Protein	I-Protein	42	43	1	1	I-NP	CD	I-protein	13	NMOD	I-protein
T2	I-Protein	I-Protein	44	52	receptor	receptor	I-NP	NN	I-protein	13	NMOD	I-protein
T2	I-Protein	I-Protein	53	63	antagonist	antagonist	I-NP	NN	O	2	PMOD	O
O	O	O	64	71	results	result	B-VP	VBZ	O	0	ROOT	O
O	O	O	72	74	in	in	B-PP	IN	O	14	VMOD	O
O	O	O	75	83	opposing	oppose	B-VP	VBG	O	17	NMOD	O
O	O	O	84	91	effects	effect	B-NP	NNS	O	15	PMOD	O
O	O	O	92	94	on	on	B-PP	IN	O	17	NMOD	O
O	O	O	95	98	HIV	HIV	B-NP	NN	O	20	NMOD	O
O	O	O	99	109	expression	expression	I-NP	NN	O	18	PMOD	O
O	O	O	110	112	in	in	B-PP	IN	O	20	NMOD	O
O	O	O	113	124	chronically	chronically	B-NP	RB	B-cell_type	25	NMOD	B-cell_type
O	O	O	125	133	infected	infected	I-NP	JJ	I-cell_type	25	NMOD	I-cell_type
O	O	O	134	143	monocytic	monocytic	I-NP	JJ	I-cell_type	25	NMOD	I-cell_type
O	O	O	144	149	cells	cell	I-NP	NNS	I-cell_type	21	PMOD	I-cell_type
O	O	O	149	150	.	.	O	.	O	14	P	O

O	O	O	152	153	A	A	B-NP	DT	O	2	NMOD	O
O	O	O	154	164	proportion	proportion	I-NP	NN	O	7	NMOD	O
O	O	O	165	167	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	168	171	HIV	HIV	B-NP	NN	O	3	PMOD	O
O	O	O	171	172	-	-	B-NP	HYPH	O	2	P	O
O	O	O	172	180	infected	infect	I-NP	VBN	O	7	NMOD	O
O	O	O	181	192	individuals	individual	I-NP	NNS	O	8	SUB	O
O	O	O	193	203	experience	experience	B-VP	VBP	O	0	ROOT	O
O	O	O	204	212	episodes	episode	B-NP	NNS	O	8	OBJ	O
O	O	O	213	215	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	216	225	localized	localized	B-NP	JJ	O	15	NMOD	O
O	O	O	226	228	or	or	I-NP	CC	O	15	NMOD	O
O	O	O	229	237	systemic	systemic	I-NP	JJ	O	15	NMOD	O
O	O	O	238	247	bacterial	bacterial	I-NP	JJ	O	15	NMOD	O
O	O	O	248	258	infections	infection	I-NP	NNS	O	10	PMOD	O
O	O	O	259	265	caused	cause	B-VP	VBN	O	15	NMOD	O
O	O	O	266	268	by	by	B-PP	IN	O	16	VMOD	O
O	O	O	269	273	Gram	Gram	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	273	274	-	-	B-NP	HYPH	O	21	P	O
O	O	O	274	282	negative	negative	I-NP	JJ	O	21	NMOD	O
O	O	O	283	291	bacteria	bacteria	I-NP	NNS	O	17	PMOD	O
O	O	O	291	292	.	.	O	.	O	8	P	O

O	O	O	293	297	Many	Many	B-NP	JJ	O	10	SUB	O
O	O	O	298	300	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	301	304	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	305	313	clinical	clinical	I-NP	JJ	O	6	NMOD	O
O	O	O	314	318	side	side	I-NP	NN	O	6	NMOD	O
O	O	O	319	326	effects	effect	I-NP	NNS	O	2	PMOD	O
O	O	O	327	329	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	330	335	these	these	B-NP	DT	O	9	NMOD	O
O	O	O	336	346	infections	infection	I-NP	NNS	O	7	PMOD	O
O	O	O	347	350	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	351	361	associated	associate	I-VP	VBN	O	10	VC	O
O	O	O	362	366	with	with	B-PP	IN	O	11	VMOD	O
O	O	O	367	370	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	371	381	production	production	I-NP	NN	O	12	PMOD	O
O	O	O	382	384	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	385	400	proinflammatory	proinflammatory	B-NP	JJ	B-protein	17	NMOD	B-protein
O	O	O	401	410	cytokines	cytokine	I-NP	NNS	I-protein	15	PMOD	I-protein
O	O	O	410	411	,	,	O	,	O	17	P	O
O	O	O	412	417	which	which	B-NP	WDT	O	17	NMOD	O
O	O	O	418	421	are	be	B-VP	VBP	O	19	SBAR	O
O	O	O	422	429	induced	induce	I-VP	VBN	O	20	VC	O
O	O	O	430	439	primarily	primarily	B-ADVP	RB	O	23	PMOD	O
O	O	O	440	442	by	by	B-PP	IN	O	21	VMOD	O
O	O	O	443	446	LPS	LPS	B-NP	NN	O	27	NMOD	O
O	O	O	446	447	,	,	O	,	O	27	P	O
O	O	O	448	449	a	a	B-NP	DT	O	27	NMOD	O
O	O	O	450	461	constituent	constituent	I-NP	NN	O	23	PMOD	O
O	O	O	462	464	of	of	B-PP	IN	O	27	NMOD	O
O	O	O	465	468	the	the	B-NP	DT	O	32	NMOD	O
O	O	O	469	478	bacterial	bacterial	I-NP	JJ	O	32	NMOD	O
O	O	O	479	483	cell	cell	I-NP	NN	O	32	NMOD	O
O	O	O	484	488	wall	wall	I-NP	NN	O	28	PMOD	O
O	O	O	489	491	of	of	B-PP	IN	O	32	NMOD	O
O	O	O	492	496	Gram	Gram	B-NP	NN	O	37	NMOD	O
O	O	O	496	497	-	-	B-NP	HYPH	O	37	P	O
O	O	O	497	505	negative	negative	I-NP	JJ	O	37	NMOD	O
O	O	O	506	514	bacteria	bacteria	I-NP	NNS	O	33	PMOD	O
O	O	O	514	515	.	.	O	.	O	10	P	O

O	O	O	516	519	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	520	527	present	present	I-NP	JJ	O	3	NMOD	O
O	O	O	528	533	study	study	I-NP	NN	O	4	SUB	O
O	O	O	534	542	examines	examine	B-VP	VBZ	O	0	ROOT	O
O	O	O	543	546	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	547	557	mechanisms	mechanism	I-NP	NNS	O	4	OBJ	O
O	O	O	558	566	involved	involve	B-VP	VBN	O	6	NMOD	O
O	O	O	567	569	in	in	B-PP	IN	O	7	VMOD	O
O	O	O	570	573	LPS	LPS	B-NP	NN	O	12	NMOD	O
O	O	O	573	574	-	-	B-NP	HYPH	O	12	NMOD	O
O	O	O	574	582	mediated	mediate	I-NP	VBN	O	12	NMOD	O
O	O	O	583	592	induction	induction	I-NP	NN	O	8	PMOD	O
O	O	O	593	595	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	596	599	HIV	HIV	B-NP	NN	O	15	NMOD	O
O	O	O	600	610	expression	expression	I-NP	NN	O	13	PMOD	O
O	O	O	611	613	in	in	B-PP	IN	O	15	NMOD	O
O	O	O	614	616	U1	U1	B-NP	NN	B-cell_line	18	NMOD	B-cell_line
O	O	O	617	622	cells	cell	I-NP	NNS	I-cell_line	23	NMOD	I-cell_line
O	O	O	622	623	,	,	O	,	O	23	P	O
O	O	O	624	625	a	a	B-NP	DT	O	23	NMOD	O
O	O	O	626	638	promonocytic	promonocytic	I-NP	JJ	B-cell_line	23	NMOD	B-cell_line
O	O	O	639	643	cell	cell	I-NP	NN	I-cell_line	23	NMOD	I-cell_line
O	O	O	644	648	line	line	I-NP	NN	I-cell_line	16	PMOD	I-cell_line
O	O	O	649	660	chronically	chronically	B-ADJP	RB	O	25	VMOD	O
O	O	O	661	669	infected	infect	I-ADJP	VBN	O	23	NMOD	O
O	O	O	670	674	with	with	B-PP	IN	O	25	VMOD	O
O	O	O	675	678	HIV	HIV	B-NP	NN	O	26	PMOD	O
O	O	O	678	679	.	.	O	.	O	4	P	O

O	O	O	680	691	Stimulation	Stimulation	B-NP	NN	O	8	SUB	O
O	O	O	692	694	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	695	697	U1	U1	B-NP	NN	B-cell_line	4	NMOD	B-cell_line
O	O	O	698	703	cells	cell	I-NP	NNS	I-cell_line	2	PMOD	I-cell_line
O	O	O	704	706	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	707	710	LPS	LPS	B-NP	NN	O	5	PMOD	O
O	O	O	711	716	alone	alone	B-ADVP	RB	O	6	NMOD	O
O	O	O	717	724	induced	induce	B-VP	VBD	O	0	ROOT	O
O	O	O	725	732	minimal	minimal	B-NP	JJ	O	10	NMOD	O
O	O	O	733	739	levels	level	I-NP	NNS	O	8	OBJ	O
O	O	O	740	742	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	743	746	HIV	HIV	B-NP	NN	O	13	NMOD	O
O	O	O	747	757	expression	expression	I-NP	NN	O	11	PMOD	O
O	O	O	757	758	,	,	O	,	O	10	P	O
O	O	O	759	764	which	which	B-NP	WDT	O	10	NMOD	O
O	O	O	765	768	was	be	B-VP	VBD	O	15	SBAR	O
O	O	O	769	782	significantly	significantly	I-VP	RB	O	16	VMOD	O
O	O	O	783	791	enhanced	enhance	I-VP	VBN	O	16	VC	O
O	O	O	792	794	by	by	B-PP	IN	O	18	VMOD	O
T3	B-Protein	B-Protein	795	806	granulocyte	granulocyte	B-NP	NN	B-protein	26	NMOD	B-protein
T3	I-Protein	I-Protein	806	807	-	-	O	HYPH	I-protein	26	NMOD	I-protein
T3	I-Protein	I-Protein	807	817	macrophage	macrophage	B-NP	NN	I-protein	26	NMOD	I-protein
T3	I-Protein	I-Protein	818	824	colony	colony	I-NP	NN	I-protein	26	NMOD	I-protein
T3	I-Protein	I-Protein	824	825	-	-	O	HYPH	I-protein	26	NMOD	I-protein
T3	I-Protein	I-Protein	825	836	stimulating	stimulate	B-VP	VBG	I-protein	26	NMOD	I-protein
T3	I-Protein	I-Protein	837	843	factor	factor	B-NP	NN	I-protein	19	PMOD	I-protein
O	O	O	844	845	(	(	O	(	O	31	DEP	O
T4	B-Protein	B-Protein	845	847	GM	GM	B-NP	NN	B-protein	30	NMOD	B-protein
T4	I-Protein	I-Protein	847	848	-	-	B-NP	HYPH	I-protein	30	P	I-protein
T4	I-Protein	I-Protein	848	851	CSF	CSF	I-NP	NN	I-protein	31	DEP	I-protein
O	O	O	851	852	)	)	O	)	O	26	NMOD	O
O	O	O	852	853	.	.	O	.	O	8	P	O

O	O	O	854	867	Costimulation	Costimulation	B-NP	NN	O	11	SUB	O
O	O	O	868	870	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	871	873	U1	U1	B-NP	NN	B-cell_line	4	NMOD	B-cell_line
O	O	O	874	879	cells	cell	I-NP	NNS	I-cell_line	2	PMOD	I-cell_line
O	O	O	880	884	with	with	B-PP	IN	O	1	NMOD	O
O	O	O	885	888	LPS	LPS	B-NP	NN	O	10	NMOD	O
O	O	O	889	893	plus	plus	I-NP	CC	O	10	NMOD	O
T5	B-Protein	B-Protein	894	896	GM	GM	I-NP	NN	B-protein	10	NMOD	B-protein
T5	I-Protein	I-Protein	896	897	-	-	O	HYPH	I-protein	10	NMOD	I-protein
T5	I-Protein	I-Protein	897	900	CSF	CSF	B-NP	NN	I-protein	5	PMOD	I-protein
O	O	O	901	909	resulted	result	B-VP	VBD	O	0	ROOT	O
O	O	O	910	912	in	in	B-PP	IN	O	11	VMOD	O
O	O	O	913	916	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	917	929	accumulation	accumulation	I-NP	NN	O	12	PMOD	O
O	O	O	930	932	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	933	939	steady	steady	B-NP	JJ	O	19	NMOD	O
O	O	O	939	940	-	-	I-NP	HYPH	O	19	NMOD	O
O	O	O	940	945	state	state	I-NP	NN	O	19	NMOD	O
O	O	O	946	952	levels	level	I-NP	NNS	O	15	PMOD	O
O	O	O	953	955	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	956	959	HIV	HIV	B-NP	NN	B-RNA	22	NMOD	B-RNA
O	O	O	960	963	RNA	RNA	I-NP	NN	I-RNA	20	PMOD	I-RNA
O	O	O	963	964	;	;	O	:	O	11	P	O
O	O	O	965	972	however	however	B-ADVP	RB	O	23	ROOT	O
O	O	O	972	973	,	,	O	,	O	24	AMOD	O
O	O	O	974	978	only	only	B-NP	RB	O	29	NMOD	O
O	O	O	979	980	a	a	I-NP	DT	O	29	NMOD	O
O	O	O	981	985	weak	weak	I-NP	JJ	O	29	NMOD	O
O	O	O	986	995	induction	induction	I-NP	NN	O	25	ROOT	O
O	O	O	996	998	of	of	B-PP	IN	O	29	NMOD	O
T18	B-Entity	B-Entity	999	1002	HIV	HIV	B-NP	NN	B-DNA	34	NMOD	B-DNA
T18	I-Entity	I-Entity	1003	1007	long	long	I-NP	JJ	I-DNA	34	NMOD	I-DNA
T18	I-Entity	I-Entity	1008	1016	terminal	terminal	I-NP	JJ	I-DNA	34	NMOD	I-DNA
T18	I-Entity	I-Entity	1017	1023	repeat	repeat	I-NP	NN	I-DNA	30	PMOD	I-DNA
O	O	O	1023	1024	-	-	O	HYPH	O	29	P	O
O	O	O	1024	1030	driven	drive	B-VP	VBN	O	29	NMOD	O
O	O	O	1031	1044	transcription	transcription	B-NP	NN	O	36	VMOD	O
O	O	O	1044	1045	,	,	O	,	O	29	P	O
O	O	O	1046	1051	which	which	B-NP	WDT	O	29	NMOD	O
O	O	O	1052	1055	was	be	B-VP	VBD	O	39	SBAR	O
O	O	O	1056	1059	not	not	I-VP	RB	O	40	VMOD	O
O	O	O	1060	1070	associated	associate	I-VP	VBN	O	40	VC	O
O	O	O	1071	1075	with	with	B-PP	IN	O	42	VMOD	O
O	O	O	1076	1079	the	the	B-NP	DT	O	45	NMOD	O
O	O	O	1080	1090	activation	activation	I-NP	NN	O	43	PMOD	O
O	O	O	1091	1093	of	of	B-PP	IN	O	45	NMOD	O
O	O	O	1094	1097	the	the	B-NP	DT	O	55	NMOD	O
O	O	O	1098	1106	cellular	cellular	I-NP	JJ	B-protein	55	NMOD	B-protein
O	O	O	1107	1120	transcription	transcription	I-NP	NN	I-protein	55	NMOD	I-protein
O	O	O	1121	1127	factor	factor	I-NP	NN	I-protein	55	NMOD	I-protein
T19	B-Entity	B-Entity	1128	1135	nuclear	nuclear	B-NP	JJ	B-protein	55	NMOD	B-protein
T19	I-Entity	I-Entity	1136	1142	factor	factor	I-NP	NN	I-protein	55	NMOD	I-protein
T19	I-Entity	I-Entity	1142	1143	-	-	B-NP	HYPH	I-protein	55	NMOD	I-protein
T19	I-Entity	I-Entity	1143	1148	kappa	kappa	I-NP	NN	I-protein	55	NMOD	I-protein
T19	I-Entity	I-Entity	1149	1150	B	B	I-NP	NN	I-protein	46	PMOD	I-protein
O	O	O	1150	1151	,	,	O	,	O	40	P	O
O	O	O	1152	1155	was	be	B-VP	VBD	O	40	VMOD	O
O	O	O	1156	1161	noted	note	I-VP	VBN	O	57	VC	O
O	O	O	1161	1162	.	.	O	.	O	29	P	O

O	O	O	1163	1176	Costimulation	Costimulation	B-NP	NN	O	10	SUB	O
O	O	O	1177	1179	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	1180	1185	cells	cell	B-NP	NNS	O	2	PMOD	O
O	O	O	1186	1190	with	with	B-PP	IN	O	1	NMOD	O
O	O	O	1191	1194	LPS	LPS	B-NP	NN	O	9	NMOD	O
O	O	O	1195	1199	plus	plus	I-NP	CC	O	9	NMOD	O
T6	B-Protein	B-Protein	1200	1202	GM	GM	I-NP	NN	B-protein	9	NMOD	B-protein
T6	I-Protein	I-Protein	1202	1203	-	-	O	HYPH	I-protein	9	NMOD	I-protein
T6	I-Protein	I-Protein	1203	1206	CSF	CSF	B-NP	NN	I-protein	4	PMOD	I-protein
O	O	O	1207	1214	induced	induce	B-VP	VBD	O	0	ROOT	O
O	O	O	1215	1218	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	1219	1229	production	production	I-NP	NN	O	34	NMOD	O
O	O	O	1230	1232	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	1233	1248	proinflammatory	proinflammatory	B-NP	JJ	B-protein	15	NMOD	B-protein
O	O	O	1249	1258	cytokines	cytokine	I-NP	NNS	I-protein	13	PMOD	I-protein
O	O	O	1258	1259	,	,	O	,	O	18	P	O
T7	B-Protein	B-Protein	1260	1262	IL	IL	B-NP	NN	B-protein	18	NMOD	B-protein
T7	I-Protein	I-Protein	1262	1263	-	-	O	HYPH	I-protein	15	NMOD	I-protein
T7	I-Protein	I-Protein	1263	1264	8	8	B-NP	CD	I-protein	18	NMOD	I-protein
O	O	O	1264	1265	,	,	O	,	O	24	P	O
T8	B-Protein	B-Protein	1266	1268	IL	IL	B-NP	NN	B-protein	24	NMOD	B-protein
T8	I-Protein	I-Protein	1268	1269	-	-	O	HYPH	I-protein	24	P	I-protein
T8	I-Protein	I-Protein	1269	1270	1	1	B-NP	CD	I-protein	24	NMOD	I-protein
T8	I-Protein	I-Protein	1271	1275	beta	beta	I-NP	SYM	I-protein	28	NMOD	I-protein
O	O	O	1276	1279	and	and	I-NP	CC	O	27	NMOD	O
T9	B-Protein	B-Protein	1280	1282	IL	IL	I-NP	NN	B-protein	27	NMOD	B-protein
T9	I-Protein	I-Protein	1282	1283	-	-	O	HYPH	I-protein	28	P	I-protein
T9	I-Protein	I-Protein	1283	1284	6	6	B-NP	CD	I-protein	15	NMOD	I-protein
O	O	O	1284	1285	,	,	O	,	O	34	P	O
O	O	O	1286	1289	but	but	O	CC	O	34	NMOD	O
O	O	O	1290	1293	not	not	O	RB	O	30	DEP	O
T10	B-Protein	B-Protein	1294	1297	TNF	TNF	B-NP	NN	B-protein	34	NMOD	B-protein
T10	I-Protein	I-Protein	1297	1298	-	-	O	HYPH	O	34	P	O
T10	I-Protein	I-Protein	1298	1303	alpha	alpha	B-NP	SYM	O	10	OBJ	O
O	O	O	1303	1304	.	.	O	.	O	10	P	O

T11	B-Protein	B-Protein	1305	1307	IL	IL	B-NP	NN	B-protein	5	NMOD	B-protein
T11	I-Protein	I-Protein	1307	1308	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T11	I-Protein	I-Protein	1308	1309	1	1	I-NP	CD	I-protein	5	NMOD	I-protein
T11	I-Protein	I-Protein	1310	1318	receptor	receptor	I-NP	NN	I-protein	5	NMOD	I-protein
T11	I-Protein	I-Protein	1319	1329	antagonist	antagonist	I-NP	NN	O	9	SUB	O
T11	I-Protein	I-Protein	1330	1331	(	(	O	(	O	8	DEP	O
T11	I-Protein	I-Protein	1331	1333	ra	ra	B-NP	NN	O	8	DEP	O
T11	I-Protein	I-Protein	1333	1334	)	)	O	)	O	5	NMOD	O
O	O	O	1335	1344	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	O	1345	1348	LPS	LPS	B-NP	NN	O	11	NMOD	O
O	O	O	1349	1360	enhancement	enhancement	I-NP	NN	O	9	OBJ	O
O	O	O	1361	1363	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	1364	1367	HIV	HIV	B-NP	NN	O	14	NMOD	O
O	O	O	1368	1378	expression	expression	I-NP	NN	O	12	PMOD	O
O	O	O	1379	1381	in	in	B-PP	IN	O	11	NMOD	O
T12	B-Protein	B-Protein	1382	1384	GM	GM	B-NP	NNP	O	21	NMOD	O
T12	I-Protein	I-Protein	1384	1385	-	-	B-NP	HYPH	O	21	P	O
T12	I-Protein	I-Protein	1385	1388	CSF	CSF	I-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	1388	1389	-	-	B-NP	HYPH	O	21	NMOD	O
O	O	O	1389	1399	stimulated	stimulate	I-NP	VBN	B-cell_type	21	NMOD	B-cell_type
O	O	O	1400	1405	cells	cell	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	O	1405	1406	,	,	O	,	O	9	P	O
O	O	O	1407	1417	suggesting	suggest	B-VP	VBG	O	9	VMOD	O
O	O	O	1418	1422	that	that	B-SBAR	IN	O	23	VMOD	O
O	O	O	1423	1433	endogenous	endogenous	B-NP	JJ	O	29	SUB	O
O	O	O	1434	1436	IL	IL	I-NP	NN	B-protein	27	NMOD	B-protein
O	O	O	1436	1437	-	-	B-NP	HYPH	I-protein	25	NMOD	I-protein
O	O	O	1437	1438	1	1	I-NP	CD	I-protein	25	NMOD	I-protein
O	O	O	1439	1442	was	be	B-VP	VBD	O	24	SBAR	O
O	O	O	1443	1451	involved	involve	I-VP	VBN	O	29	VC	O
O	O	O	1452	1454	in	in	B-PP	IN	O	30	VMOD	O
O	O	O	1455	1458	LPS	LPS	B-NP	NN	O	36	NMOD	O
O	O	O	1458	1459	-	-	O	HYPH	O	32	P	O
O	O	O	1459	1467	mediated	mediate	B-VP	VBN	O	32	AMOD	O
O	O	O	1468	1473	viral	viral	B-NP	JJ	O	36	NMOD	O
O	O	O	1474	1484	production	production	I-NP	NN	O	31	PMOD	O
O	O	O	1484	1485	.	.	O	.	O	9	P	O

O	O	O	1486	1488	In	In	B-PP	IN	O	9	VMOD	O
O	O	O	1489	1493	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	1494	1500	regard	regard	I-NP	NN	O	1	PMOD	O
O	O	O	1500	1501	,	,	O	,	O	9	P	O
O	O	O	1502	1506	anti	anti	B-NP	AFX	O	8	NMOD	O
O	O	O	1506	1507	-	-	I-NP	HYPH	O	8	NMOD	O
O	O	O	1507	1519	inflammatory	inflammatory	B-NP	JJ	B-protein	8	NMOD	B-protein
O	O	O	1520	1529	cytokines	cytokine	I-NP	NNS	I-protein	9	SUB	I-protein
O	O	O	1530	1539	inhibited	inhibit	B-VP	VBD	O	24	VMOD	O
O	O	O	1540	1543	LPS	LPS	B-NP	NN	O	14	NMOD	O
O	O	O	1544	1548	plus	plus	I-NP	CC	O	14	NMOD	O
T13	B-Protein	B-Protein	1549	1551	GM	GM	I-NP	NN	B-protein	14	NMOD	B-protein
T13	I-Protein	I-Protein	1551	1552	-	-	I-NP	HYPH	I-protein	14	P	I-protein
T13	I-Protein	I-Protein	1552	1555	CSF	CSF	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	O	1555	1556	-	-	I-NP	HYPH	O	18	NMOD	O
O	O	O	1556	1566	stimulated	stimulate	I-NP	VBN	O	18	NMOD	O
O	O	O	1567	1570	HIV	HIV	I-NP	NN	O	18	NMOD	O
O	O	O	1571	1581	expression	expression	I-NP	NN	O	9	OBJ	O
O	O	O	1581	1582	,	,	O	,	O	24	P	O
O	O	O	1583	1586	and	and	O	CC	O	24	VMOD	O
O	O	O	1587	1591	this	this	B-NP	DT	O	22	NMOD	O
O	O	O	1592	1598	effect	effect	I-NP	NN	O	24	SUB	O
O	O	O	1599	1606	closely	closely	B-ADVP	RB	O	24	VMOD	O
O	O	O	1607	1617	correlated	correlate	B-VP	VBD	O	0	ROOT	O
O	O	O	1618	1622	with	with	B-PP	IN	O	24	VMOD	O
O	O	O	1623	1633	inhibition	inhibition	B-NP	NN	O	25	PMOD	O
O	O	O	1634	1636	of	of	B-PP	IN	O	26	NMOD	O
T14	B-Protein	B-Protein	1637	1639	IL	IL	B-NP	NN	B-protein	32	NMOD	B-protein
T14	I-Protein	I-Protein	1639	1640	-	-	O	HYPH	I-protein	32	NMOD	I-protein
T14	I-Protein	I-Protein	1640	1641	1	1	B-NP	CD	I-protein	32	NMOD	I-protein
T14	I-Protein	I-Protein	1642	1646	beta	beta	I-NP	SYM	I-protein	32	NMOD	I-protein
O	O	O	1647	1654	release	release	I-NP	NN	O	27	PMOD	O
O	O	O	1655	1658	and	and	O	CC	O	24	VMOD	O
O	O	O	1658	1659	,	,	O	,	O	24	P	O
O	O	O	1660	1662	in	in	B-PP	IN	O	24	VMOD	O
O	O	O	1663	1673	particular	particular	B-ADJP	JJ	O	35	PMOD	O
O	O	O	1673	1674	,	,	O	,	O	35	P	O
O	O	O	1675	1679	with	with	B-PP	IN	O	35	PMOD	O
O	O	O	1680	1682	up	up	B-ADVP	RB	O	40	AMOD	O
O	O	O	1682	1683	-	-	O	HYPH	O	35	PMOD	O
O	O	O	1683	1693	regulation	regulation	B-NP	NN	O	40	OBJ	O
O	O	O	1694	1696	of	of	B-PP	IN	O	41	NMOD	O
O	O	O	1697	1707	endogenous	endogenous	B-NP	JJ	O	47	NMOD	O
T15	B-Protein	B-Protein	1708	1710	IL	IL	I-NP	NN	O	47	NMOD	O
T15	I-Protein	I-Protein	1710	1711	-	-	B-NP	HYPH	O	47	NMOD	O
T15	I-Protein	I-Protein	1711	1714	1ra	1ra	I-NP	NN	O	47	NMOD	O
O	O	O	1715	1725	production	production	I-NP	NN	O	42	PMOD	O
O	O	O	1725	1726	.	.	O	.	O	24	P	O

O	O	O	1727	1731	Thus	Thus	B-ADVP	RB	O	25	VMOD	O
O	O	O	1731	1732	,	,	O	,	O	25	P	O
O	O	O	1733	1736	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	1737	1744	balance	balance	I-NP	NN	O	25	SUB	O
O	O	O	1745	1752	between	between	B-PP	IN	O	4	NMOD	O
O	O	O	1753	1755	an	an	B-NP	DT	O	10	NMOD	O
O	O	O	1756	1768	endogenously	endogenously	I-NP	RB	O	10	NMOD	O
O	O	O	1769	1777	produced	produce	I-NP	VBN	O	10	NMOD	O
O	O	O	1778	1783	viral	viral	I-NP	JJ	O	10	NMOD	O
O	O	O	1784	1791	inducer	inducer	I-NP	NN	O	19	NMOD	O
O	O	O	1792	1793	(	(	O	(	O	16	DEP	O
T16	B-Protein	B-Protein	1793	1795	IL	IL	B-NP	NN	B-protein	15	NMOD	B-protein
T16	I-Protein	I-Protein	1795	1796	-	-	O	HYPH	I-protein	15	P	I-protein
T16	I-Protein	I-Protein	1796	1797	1	1	B-NP	CD	I-protein	15	NMOD	I-protein
T16	I-Protein	I-Protein	1798	1802	beta	beta	B-NP	SYM	I-protein	16	DEP	I-protein
O	O	O	1803	1804	)	)	O	)	O	10	NMOD	O
O	O	O	1805	1808	and	and	O	CC	O	19	NMOD	O
O	O	O	1809	1811	an	an	B-NP	DT	O	19	NMOD	O
O	O	O	1812	1821	inhibitor	inhibitor	I-NP	NN	O	5	PMOD	O
O	O	O	1822	1823	(	(	O	(	O	24	DEP	O
T17	B-Protein	B-Protein	1823	1825	IL	IL	B-NP	NN	B-protein	23	NMOD	B-protein
T17	I-Protein	I-Protein	1825	1826	-	-	B-NP	HYPH	I-protein	23	P	I-protein
T17	I-Protein	I-Protein	1826	1829	1ra	1ra	I-NP	NN	I-protein	24	DEP	I-protein
O	O	O	1829	1830	)	)	O	)	O	19	NMOD	O
O	O	O	1831	1834	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	1835	1844	represent	represent	I-VP	VB	O	25	VC	O
O	O	O	1845	1847	an	an	B-NP	DT	O	29	NMOD	O
O	O	O	1848	1857	important	important	I-NP	JJ	O	29	NMOD	O
O	O	O	1858	1865	pathway	pathway	I-NP	NN	O	26	OBJ	O
O	O	O	1866	1873	leading	lead	B-VP	VBG	O	29	NMOD	O
O	O	O	1874	1876	to	to	B-PP	TO	O	30	VMOD	O
O	O	O	1877	1887	modulation	modulation	B-NP	NN	O	31	PMOD	O
O	O	O	1888	1890	of	of	B-PP	IN	O	32	NMOD	O
O	O	O	1891	1894	HIV	HIV	B-NP	NN	O	35	NMOD	O
O	O	O	1895	1905	expression	expression	I-NP	NN	O	33	PMOD	O
O	O	O	1906	1910	from	from	B-PP	IN	O	35	NMOD	O
O	O	O	1911	1920	monocytic	monocytic	B-NP	JJ	B-cell_type	38	NMOD	B-cell_type
O	O	O	1921	1926	cells	cell	I-NP	NNS	I-cell_type	36	PMOD	I-cell_type
O	O	O	1926	1927	.	.	O	.	O	25	P	O
